Literature DB >> 15019163

Loss of heterozygosity and p53 expression in Pterygium.

David Reisman1, Jennifer Wallace McFadden, Gary Lu.   

Abstract

While the pathogenesis of pterygium is still not well understood, environmental factors such at UV light, appear to play an important role in its development. UV radiation can cause mutations in genes such as the p53 tumor suppressor gene, that when inactivated through mutation and loss of heterozygosity can lead to cell proliferation and genomic instability. However, aside from mutations in the gene, other mechanisms have been identified that can lead to loss of p53 function. These include the interaction of the p53 protein with cellular or viral gene products that lead to the inactivation of p53 or to its rapid degradation as well as the silencing of transcription of the p53 gene through the aberrant expression of factors that control p53 expression. We have analyzed the status and expression of the p53 gene in epithelial cells derived from pterygium and have demonstrated that the p53 gene has undergone a monoallelic deletion. Assays for both p53 protein and mRNA revealed that the remaining allele in these cells is not expressed at detectable levels. Furthermore, the remaining allele, by DNA sequence analysis appears to remain wild type. The mechanism of silencing the p53 gene and the loss of p53 expression in these cells is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019163     DOI: 10.1016/j.canlet.2003.10.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  New approach for pterygium removal using 20 % ethanol.

Authors:  Erez Tsumi; Jaime Levy; Anry Pitchkhadze; Amjad Baidousi; Tova Lifshitz
Journal:  Int Ophthalmol       Date:  2012-06-21       Impact factor: 2.031

Review 2.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

3.  Atypical U3 snoRNA Suppresses the Process of Pterygium Through Modulating 18S Ribosomal RNA Synthesis.

Authors:  Xin Zhang; Yaping Jiang; Qian Wang; Weishu An; Xiaoyan Zhang; Ming Xu; Yihui Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

4.  Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia.

Authors:  Shahram Bamdad; Behzad Khademi; Nooshin Chenari; Atta Taseh; Mahboobeh Razmkhah
Journal:  J Curr Ophthalmol       Date:  2016-12-27

5.  Vitamin D and vitamin D receptor in patients with ophthalmic pterygium.

Authors:  Cristina Maxia; Daniela Murtas; Michela Corrias; Ignazio Zucca; Luigi Minerba; Franca Piras; Cristiana Marinelli; Maria Teresa Perra
Journal:  Eur J Histochem       Date:  2017-10-30       Impact factor: 3.188

6.  Prevalence of Pterygium and Associated Risk Factors in the High-Altitude Area of Ta'if City, Saudi Arabia.

Authors:  Ruba Qadi; Ahmed AlAmri; Manal Elnashar; Jehan F Sarriyah; Abdulmalik H Alghamdi; Khaled Fahad Alsolami; Ashwaq M Almalki; Faisal Alotaibi
Journal:  Cureus       Date:  2021-01-11

7.  4-Hydroxyhexenal- and 4-hydroxynonenal-modified proteins in pterygia.

Authors:  Ichiya Sano; Sachiko Kaidzu; Masaki Tanito; Katsunori Hara; Tsutomu Okuno; Akihiro Ohira
Journal:  Oxid Med Cell Longev       Date:  2013-05-12       Impact factor: 6.543

8.  p53 expression in pterygium in two climatic regions in Turkey.

Authors:  Aysel Pelit; Nebil Bal; Yonca A Akova; Beyhan Demirhan
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

9.  Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium.

Authors:  Cristina Maxia; Maria Teresa Perra; Paolo Demurtas; Luigi Minerba; Daniela Murtas; Franca Piras; Renè Cabrera; Domenico Ribatti; Paola Sirigu
Journal:  Mol Vis       Date:  2009-02-27       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.